Markouli, M.; Ullah, F.; Unlu, S.; Omar, N.; Lopetegui-Lia, N.; Duco, M.; Anwer, F.; Raza, S.; Dima, D.
Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management. Curr. Oncol. 2023, 30, 6330-6352.
https://doi.org/10.3390/curroncol30070467
AMA Style
Markouli M, Ullah F, Unlu S, Omar N, Lopetegui-Lia N, Duco M, Anwer F, Raza S, Dima D.
Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management. Current Oncology. 2023; 30(7):6330-6352.
https://doi.org/10.3390/curroncol30070467
Chicago/Turabian Style
Markouli, Mariam, Fauzia Ullah, Serhan Unlu, Najiullah Omar, Nerea Lopetegui-Lia, Marissa Duco, Faiz Anwer, Shahzad Raza, and Danai Dima.
2023. "Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management" Current Oncology 30, no. 7: 6330-6352.
https://doi.org/10.3390/curroncol30070467
APA Style
Markouli, M., Ullah, F., Unlu, S., Omar, N., Lopetegui-Lia, N., Duco, M., Anwer, F., Raza, S., & Dima, D.
(2023). Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management. Current Oncology, 30(7), 6330-6352.
https://doi.org/10.3390/curroncol30070467